Novel oligonucleotide assay detects HBV pre-core and basal core mutations in HBV-infected Gambians

Novel oligonucleotide assay detects HBV pre-core and basal core mutations in HBV-infected Gambians

Dades bibliogràfiques
Autors principals:	Mendy, M, Kirk, G, Jeng-Barry, A, Kaye, S, McConkey, S, Le Roux, E, Hainaut, P, Whittle, H, Rowland-Jones, S
Format:	Conference item
Publicat:	2006

Ítems similars

Application of a novel, rapid, and sensitive oligonucleotide ligation assay for detection of cancer-predicting mutations in the precore and basal core promoter of hepatitis B virus.
per: Mendy, M, et al.
Publicat: (2008)

KIR content genotypes associate with carriage of hepatitis B surface antigen, e antigen and HBV viral load in Gambians
per: Yindom, L, et al.
Publicat: (2017)

KIR content genotypes associate with carriage of hepatitis B surface antigen, e antigen and HBV viral load in Gambians.
per: Louis-Marie Yindom, et al.
Publicat: (2017-01-01)

Partially randomized, non-blinded trial of DNA and MVA therapeutic vaccines based on hepatitis B virus surface protein for chronic HBV infection.
per: Cavenaugh, J, et al.
Publicat: (2011)

Analysis of HBV basal core promoter/precore gene variability in patients with HBV drug resistance and HIV co-infection in Northwest Ethiopia.
per: Yeshambel Belyhun, et al.
Publicat: (2018-01-01)

Mutations in pre-core and basal-core promoter regions of hepatitis B virus in chronic HBV patients from Golestan, Iran
per: Abdolvahab Moradi, et al.
Publicat: (2014-05-01)

Changes in viral load and HBsAg and HBeAg status with age in HBV chronic carriers in The Gambia
per: Crozier Sarah, et al.
Publicat: (2008-04-01)

HBV Core Protein Enhances Cytokine Production
per: Tatsuo Kanda, et al.
Publicat: (2015-09-01)

Development and evaluation of an oligonucleotide ligation assay for detection of drug resistance-associated mutations in the human immunodeficiency virus type 2 pol gene.
per: Jallow, S, et al.
Publicat: (2007)

Partially randomized, non-blinded trial of DNA and MVA therapeutic vaccines based on hepatitis B virus surface protein for chronic HBV infection.
per: James S Cavenaugh, et al.
Publicat: (2011-02-01)

Colchicine-mediated selective autophagic degradation of HBV core proteins inhibits HBV replication and HBV-related hepatocellular carcinoma progression
per: Hui Zhang, et al.
Publicat: (2024-08-01)

New biomarkers of hepatitis B virus (HBV) infection: HBV RNA and HBV core-related antigen, new kids on the block?
per: Young-Suk Lim
Publicat: (2023-01-01)

Emergence of HBV resistance to lamivudine (3TC) in HIV/HBV co-infected patients in The Gambia, West Africa.
per: Stewart, B, et al.
Publicat: (2011)

Hepatitis B virus genotypes, precore mutations, and basal core promoter mutations in HBV-infected Chinese patients with persistently normal alanine aminotransferase and low serum HBV-DNA levels
per: Ming Shi, et al.

Emergence of HBV resistance to lamivudine (3TC) in HIV/HBV co-infected patients in The Gambia, West Africa
per: Stewart Balint, et al.
Publicat: (2011-12-01)

Targeting the HIV-1 and HBV Capsids, an EnCore
per: William M. McFadden, et al.
Publicat: (2023-03-01)

Safety, immunogenicity, and efficacy results of a phase II trial of therapeutic vaccines for chronic HBV in the Gambia.
per: McConkey, S, et al.
Publicat: (2004)

The proteasome activator subunit PSME1 promotes HBV replication by inhibiting the degradation of HBV core protein
per: Yu Liu, et al.
Publicat: (2024-11-01)

Inhibition of the HCV core protein on the immune response to HBV surface antigen and on HBV gene expression and replication in vivo.
per: Wenbo Zhu, et al.
Publicat: (2012-01-01)

Differences in HBV Replication, APOBEC3 Family Expression, and Inflammatory Cytokine Levels Between Wild-Type HBV and Pre-core (G1896A) or Basal Core Promoter (A1762T/G1764A) Mutants
per: Keith C. K. Lau, et al.
Publicat: (2020-07-01)

Hepatitis B virus genotypes and mutations in the basal core promoter and pre-core/core in chronically infected patients in southern Brazil: a cross-sectional study of HBV genotypes and mutations in chronic carriers
per: Flávia Miryan Martins Almeida de Mello, et al.
Publicat: (2014-12-01)

Hepatitis B viral load and risk for liver cirrhosis and hepatocellular carcinoma in The Gambia, West Africa.
per: Mendy, M, et al.
Publicat: (2010)

Anti-Retroviral Therapy (ART) Monitoring and the Development of the Oligonucleotide Ligation Assay for Detecting Critical Drug-resistant Mutations in HIV-2 Patients in Preparation of the Global Fund Initiative in The Gambia
per: Rowland-Jones Sarah, et al.
Publicat: (2005-12-01)

Intrahepatic quantification of HBV antigens in chronic hepatitis B reveals heterogeneity and treatment-mediated reductions in HBV core-positive cells
per: Abhishek Aggarwal, et al.
Publicat: (2023-04-01)

HBV Core Promoter Inhibition by Tubulin Polymerization Inhibitor (SRI-32007)
per: Raj Kalkeri, et al.
Publicat: (2020-01-01)

Clinical Utility of Quantitative HBV Core Antibodies for Solving Diagnostic Dilemmas
per: Ivana Lazarevic, et al.
Publicat: (2023-01-01)

Screening and identification of compounds inhibiting transcriptional activity of HBV core promoter
per: SUN Yuxue, et al.
Publicat: (2021-07-01)

HBV Core Protein Is in Flux between Cytoplasmic, Nuclear, and Nucleolar Compartments
per: Smita Nair, et al.
Publicat: (2021-02-01)

IL-15 boosts activated HBV core-specific CD8+ progenitor cells via metabolic rebalancing in persistent HBV infection
per: Julia Peña-Asensio, et al.
Publicat: (2024-01-01)

S gene mutations of HBV in children with HBV-associated glomerulonephritis
per: Lu Hongzhu, et al.
Publicat: (2012-03-01)

Blood donors with HBV core anti-body: a follow-up study
per: Lu ZHOU, et al.
Publicat: (2023-02-01)

Allosteric conformational changes of human HBV core protein transform its assembly
per: Chuang Liu, et al.
Publicat: (2017-05-01)

Chronicles of HBV and the Road to HBV Cure
per: Rukaiya Bashir Hamidu, et al.
Publicat: (2023-04-01)

Monitoring the emergence of HBV resistance mutations by HBV-RNA pyrosequencing
per: Marcelle Bottecchia, et al.
Publicat: (2016-03-01)

C-terminal substitution of HBV core proteins with those from DHBV reveals that arginine-rich 167RRRSQSPRR175 domain is critical for HBV replication.
per: Jaesung Jung, et al.
Publicat: (2012-01-01)

CAM-A-dependent HBV core aggregation induces apoptosis through ANXA1
per: Valerio Taverniti, et al.
Publicat: (2024-10-01)

Clinical Significance and Remaining Issues of Anti-HBc Antibody and HBV Core-Related Antigen
per: Yoshihiko Yano, et al.
Publicat: (2024-03-01)

Development and evaluation of the oligonucleotide ligation assay (OLA) for the detection of drug resistance mutations in HIV-2 patients on antiretroviral therapy
per: Jallow, S, et al.
Publicat: (2006)

DNA immunization with fusion of CTLA-4 to hepatitis B virus (HBV) core protein enhanced Th2 type responses and cleared HBV with an accelerated kinetic.
per: Ying Yin, et al.
Publicat: (2011-01-01)

HBV-RNA, Quantitative HBsAg, Levels of HBV in Peripheral Lymphocytes and HBV Mutation Profiles in Chronic Hepatitis B
per: Yael Gozlan, et al.
Publicat: (2022-03-01)